74
Participants
Start Date
September 30, 2012
Primary Completion Date
April 30, 2014
Study Completion Date
January 31, 2015
Monthly Financial Incentive
A cash payment.
Final Financial Incentive
One-time payment in cash for each full percentage of hemoglobin A1c decrease over the eight-month period of the study.
Boston Medical Center, Boston
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
National Bureau of Economic Research, Inc.
OTHER
Boston Medical Center
OTHER